The long-running antitrust saga involving alleged efforts to block generic competition for the wakefulness drug Provigil appears to have reached its conclusion.
Insurance giant
United settled on undisclosed terms with the remaining defendants,
United appears to have been the last plaintiff out of hundreds that accused Cephalon Inc. of resolving its patent infringement ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.